Search

Hoa T Le

Examiner (ID: 13075, Phone: (571)272-1511 , Office: P/1788 )

Most Active Art Unit
1788
Art Unit(s)
1794, 1787, 1316, 2899, 1773, 1788, 1509, 1709
Total Applications
2557
Issued Applications
1900
Pending Applications
185
Abandoned Applications
471

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18526358 [patent_doc_number] => 11713344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Acylated oxyntomodulin peptide analog [patent_app_type] => utility [patent_app_number] => 17/410697 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 11158 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410697
Acylated oxyntomodulin peptide analog Aug 23, 2021 Issued
Array ( [id] => 17685891 [patent_doc_number] => 20220193183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE [patent_app_type] => utility [patent_app_number] => 17/390165 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6907 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390165 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/390165
COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE Jul 29, 2021 Pending
Array ( [id] => 17355423 [patent_doc_number] => 20220016219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => Means and Methods to Treat Diabetes [patent_app_type] => utility [patent_app_number] => 17/387788 [patent_app_country] => US [patent_app_date] => 2021-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387788 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/387788
Means and Methods to Treat Diabetes Jul 27, 2021 Pending
Array ( [id] => 17213122 [patent_doc_number] => 20210346458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN [patent_app_type] => utility [patent_app_number] => 17/384478 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384478 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/384478
COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN Jul 22, 2021 Abandoned
Array ( [id] => 17414044 [patent_doc_number] => 20220048948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => CD40 TARGETED PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/380303 [patent_app_country] => US [patent_app_date] => 2021-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 75329 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380303 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/380303
CD40 TARGETED PEPTIDES AND USES THEREOF Jul 19, 2021 Pending
Array ( [id] => 17213032 [patent_doc_number] => 20210346368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/379369 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379369 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/379369
ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS Jul 18, 2021 Pending
Array ( [id] => 17198687 [patent_doc_number] => 20210338781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY [patent_app_type] => utility [patent_app_number] => 17/366453 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/366453
METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY Jul 1, 2021 Pending
Array ( [id] => 17299470 [patent_doc_number] => 20210395309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => PEPTIDE-DRUG CONJUGATES [patent_app_type] => utility [patent_app_number] => 17/304472 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12087 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/304472
PEPTIDE-DRUG CONJUGATES Jun 21, 2021 Pending
Array ( [id] => 19058973 [patent_doc_number] => 11938166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => Methods and compositions for treating mucosal tissue disorders [patent_app_type] => utility [patent_app_number] => 17/348096 [patent_app_country] => US [patent_app_date] => 2021-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 42883 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348096 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/348096
Methods and compositions for treating mucosal tissue disorders Jun 14, 2021 Issued
Array ( [id] => 17126220 [patent_doc_number] => 20210300988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => ANTI-KRAS-G12D T CELL RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/345390 [patent_app_country] => US [patent_app_date] => 2021-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18667 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 312 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345390 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/345390
Anti-KRAS-G12D T cell receptors Jun 10, 2021 Issued
Array ( [id] => 17482156 [patent_doc_number] => 20220089660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/324501 [patent_app_country] => US [patent_app_date] => 2021-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324501 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/324501
IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF May 18, 2021 Pending
Array ( [id] => 17098180 [patent_doc_number] => 20210285971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => USE OF Ass34 TO ASSESS ALZHEIMER'S DISEASE PROGRESSION [patent_app_type] => utility [patent_app_number] => 17/323312 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323312 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/323312
USE OF Ass34 TO ASSESS ALZHEIMER'S DISEASE PROGRESSION May 17, 2021 Pending
Array ( [id] => 17314556 [patent_doc_number] => 20210403604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => Liposome Binding Peptide, Construct for Manufacturing the Liposome Binding Peptide, and Liposome [patent_app_type] => utility [patent_app_number] => 17/315041 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315041 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/315041
Liposome Binding Peptide, Construct for Manufacturing the Liposome Binding Peptide, and Liposome May 6, 2021 Pending
Array ( [id] => 17126209 [patent_doc_number] => 20210300977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/244973 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7074 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244973 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/244973
CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME Apr 29, 2021 Abandoned
Array ( [id] => 17243462 [patent_doc_number] => 20210363205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND MITOCHONDRIA ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 17/246549 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/246549
Methods for treating myelin associated diseases and mitochondria associated diseases Apr 29, 2021 Issued
Array ( [id] => 17414042 [patent_doc_number] => 20220048946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => CYCLIC TETRAPEPTIDE STEREOISOMERS [patent_app_type] => utility [patent_app_number] => 17/240638 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240638 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/240638
CYCLIC TETRAPEPTIDE STEREOISOMERS Apr 25, 2021 Abandoned
Array ( [id] => 18887756 [patent_doc_number] => 11866518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Bicyclic peptide ligands specific for TSLP [patent_app_type] => utility [patent_app_number] => 17/223244 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20873 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 390 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223244 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/223244
Bicyclic peptide ligands specific for TSLP Apr 5, 2021 Issued
Array ( [id] => 18028950 [patent_doc_number] => 11512123 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Method for removing water from compound solution and performing conjugate acid conversion [patent_app_type] => utility [patent_app_number] => 17/184164 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4895 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184164 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/184164
Method for removing water from compound solution and performing conjugate acid conversion Feb 23, 2021 Issued
Array ( [id] => 16932440 [patent_doc_number] => 20210198329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => PEPTIDES FOR TARGETING LRP6-OVEREXPRESSED CELLS [patent_app_type] => utility [patent_app_number] => 17/175704 [patent_app_country] => US [patent_app_date] => 2021-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175704 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/175704
Peptides for targeting LRP6-overexpressed cells Feb 14, 2021 Issued
Array ( [id] => 18619110 [patent_doc_number] => 11752132 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Materials and methods for improving gastrointestinal function [patent_app_type] => utility [patent_app_number] => 17/161811 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 46 [patent_no_of_words] => 22526 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161811 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/161811
Materials and methods for improving gastrointestinal function Jan 28, 2021 Issued
Menu